Categories
Categories
Brands
Brands
- Home
- Interventional Cardiology / Radiology / Electrophy
- ST. JUDE MEDICAL
- St. Jude medical CD3357-40Q UNIFY ASSURA ™ Cardiac Resynchronization Therapy (CRT) Defibrillator
- Home
- Interventional Cardiology / Radiology / Electrophy
- Abbott
- St. Jude medical CD3357-40Q UNIFY ASSURA ™ Cardiac Resynchronization Therapy (CRT) Defibrillator
St. Jude medical CD3357-40Q UNIFY ASSURA ™ Cardiac Resynchronization Therapy (CRT) Defibrillator
$79,395.00
St. Jude medical CD3357-40Q UNIFY ASSURA ™ Cardiac Resynchronization Therapy (CRT) Defibrillator
$79,395.00
Product Description
CD3357-40Q Bi-ventricular ICD Unify Assura Next Generation CRT-D 40 DF4 Connector
UNIFY ASSURA ™
CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D)
PRODUCT HIGHLIGHTS
- TailoredTherapy™ features are designed to customize treatment to each patient's unique needs, including: SecureSense™ RV lead noise discrimination, ShockGuard® technology, SenseAbility® sensing algorithm and DeFT Response® technology
- ShockGuard technology with DecisionTx® programming is designed to reduce inappropriate therapy and minimize the need for programming adjustments at implant
- SecureSense RV lead noise discrimination detects sustained and short bursts of lead noise for the reduction of inappropriate shocks
- Antitachycardia pacing (ATP) while charging and prior to charging in the VF zone further extends the programming options for terminating tachyarrhythmias without a high-voltage shock
- The Low Frequency Attenuation filter is designed to enhance sensing performance and may reduce the possibility of oversensing T waves
- Complete capture confirmation accounts for changing thresholds by automatically monitoring and controlling pacing amplitudes in all chambers of the heart
- ACap® Confirm assesses capture threshold and adjusts pacing amplitudes in the atrium every eight or 24 hours
- The SenseAbility sensing algorithm allows flexibility to fine-tune programming around T-wave oversensing without decreasing sensitivity
- Streamlined DF4 connector simplifies implants and reduces pocket bulk
- Highest amount of delivered energy (40 J) provides a greater safety margin
- DeFT Response technology offers the most noninvasive options for managing high defibrillation thresholds (DFTs)
- QHR®* battery chemistry provides greater capacity for enhanced longevity and improved charge time performance compared to previous SVO batteries
- Unique vibratory notifier alerts patients to low battery, lead-related complications and more
- Smallest footprint of any high-voltage device available and narrow shape allow smaller incision and pocket size
- Triggered pacing with BiVCap® Confirm Trigger Mode helps maintain a high percentage of biventricular (BiV) pacing by triggering pacing in both the left and right ventricles in response to a sensed ventricular event
- Negative AV hysteresis with search promotes ventricular pacing by automatically reducing the AV delay when intrinsic activity is present, thereby promoting a high degree of ventricular pacing
- QuickOpt® Timing Cycle Optimization provides quick and effective AV and V-V timing optimization at the push of a button